The Cooper Companies, Inc. vs Abbvie Inc.
COO vs ABBV — side-by-side comparison from reported financials. COO leads 5, ABBV leads 6 of 11 comparable metrics.
The Cooper Companies, Inc.
COO · Healthcare
$54.37+0.13%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | COO | ABBV |
|---|---|---|
| Price | $54.37 | $276.43 |
| Market cap | $10.3B | $488B |
| Revenue (TTM) | $4.24B | $64.4B |
| Revenue growth | +7.3% | +1.8% |
| Net margin | 13.5% | 9.8% |
| Free cash flow | $678M | $18.2B |
| Net cash (debt) | ($2.39B) | ($56.2B) |
| 1-year price return | -22.1% | +19.8% |
| P/E | 18.1 | 77.4 |
| P/E vs own history (cheap-side %) | 89% | 23% |
| Dividend yield | 0.00% | 2.45% |
| Return on equity | 7% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 8 of 11 | 9 of 11 |
| Employees | 15,000 | 57,000 |
Full résumé-style profiles: COO CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.